Selective cyclooxygenase-2 inhibitor may impair bone healing around titanium implants in rats

Journal of Periodontology

Volumn 77, Issue 10, 2006, Pages 1731-1735

  Ribeiro, Fernanda V ^a   César Neto, João B ^a   Nociti Jr , Francisco H ^a   Sallum, Enilson A ^a   Sallum, Antonio W ^a   De Toledo, Sérgio ^a   Casati, Márcio Zaffalon ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Anti inflammatory agents; Cyclooxygenase 2 inhibitors; Dental implants; Osseointegration; Wound healing

Indexed keywords

ANTIBIOTIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; MELOXICAM; MOVATEC; PENTABIOTICO; SODIUM CHLORIDE; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BONE DENSITY; BONE REGENERATION; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; DRUG SELECTIVITY; HEALING IMPAIRMENT; MALE; NONHUMAN; RANDOM SAMPLE; RAT; RAT STRAIN; TIBIA; TOOTH IMPLANTATION;

ANIMALS; BONE DENSITY; CYCLOOXYGENASE 2 INHIBITORS; DENTAL IMPLANTS; INJECTIONS, SUBCUTANEOUS; MALE; OSSEOINTEGRATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; THIAZINES; THIAZOLES; TIBIA; TITANIUM; WOUND HEALING;

EID: 33750587839     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.060119     Document Type: Article

References (40)

1. Payne JB, Reinhardt RA, Nummikoski PV, Dunning DG, Patil KD. The association of cigarette smoking with alveolar bone loss in postmenopausal females. J Clin Periodontol 2000;27:658-664.
2. Rapuri PB, Gallacher JC, Balhorn KE, Ryschon KL. Smoking and bone metabolism in elderly women. Bone 2000;27:429-436.
3. César-Neto JB, Benatti BB, Sallum EA, Sallum AW, Nociti FH Jr. Bone filling around titanium implants may benefit from smoking cessation: A histologic study in rats. J Periodontol 2005;76:1476-1481.
4. Duarte PM, Gonçalves PF, Casati MZ, Sallum EA, Nociti FH Jr. Age-related and surgically induced estrogen deficiencies may differently affect bone around titanium implants in rats. J Periodontol 2005; 76:1496-1501.
5. Altman RD, Latta LL, Keer R, Renfree K, Hornicek FJ, Banovac K. Effect of nonsteroidal antiinflammatory drugs on fracture healing: A laboratory study in rats. J Orthop Trauma 1995;9:392-400.
6. Bichara J, Greenwell H, Drisco C, Wittwer JW, Vest TM, Yancey J. The effect of postsurgical naproxen and a bioabsorbable membrane on osseous healing in intrabony defects. J Periodontol 1999;70:869-877.
7. Giordano V, Giordano M, Knackfuss IG, Apfel MI, Gomes RD. Effect of tenoxicam on fracture healing in rat tibiae. Injury 2003;34:85-94.
8. Reddy MS, Jeffcoat MK, Richardson RC. Assessment of adjunctive flurbiprofen therapy in root-form implant healing with digital subtraction radiography. J Oral Implantol 1990;16:272-276.
9. Lemmel EM, Bolten W, Burgos-Vargas R, et al. Efficacy and safety of meloxicam in patients with rheumatoid arthritis. J Rheumatol 1997;24:282-290.
10. Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG. The role of Prostaglandins in the regulation of bone metabolism. Clin Orthop 1995;313:36-46.
11. Weinreb M, Suponitzky I, Keila S. Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow. Bone 1997;20:521-526.
12. Gurgel BCV, Ribeiro FV, Silva MAD, et al. Selective COX-2 inhibitor reduces bone healing in bone defects. Pesqui Odontol Bras 2005;19:312-316.
13. 2 on bone mass in rat long bones and calvariae. J Endocrinol 1998;156:51-57.
14. Sato Y, Arai IY, Negishi A, Ohya K. Expression of cyclooxygenase genes and involvement of endogenous prostaglandin during osteogenesis in the rat tibial bone marrow cavity. J Med Dent Sci 1997;44:81-92.
15. 2 in human mesenchymal stem cells. J Cell Physiol 2004;200:400-406.
16. Simon AM, Manigrasso MB, O'Connor JP. Cyclooxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002;17:963-976.
17. Jacobsson SA, Djerf K, Ivarsson I, Wahlstrom O. Effect of diclofenac on fixation of hydroxyapatite-coated implants. An experimental study. J Bone Joint Surg Br 1994;76:831-833.
18. Nociti FH Jr., César-Veto JB, Carvalho MD, Sallum EA. Bone density around titanium implants may be influenced by intermittent cigarette smoke inhalation: A histometric study in rats. Int J Oral Maxillofac Implants 2002;17:347-352.
19. Bezerra MM, Lima V, Alencar VBM, et al. Selective cyclooxygenase-2 inhibitor prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000;71:1009-1014.
20. Gurgel BCV, Duarte PM, Nociti FH Jr., et al. Impact of an anti-inflammatory therapy and its withdrawal on the progression of experimental periodontitis in rats. J Periodontol 2004;75:1613-1618.
21. Donath K, Breuner GA. A method for the study of undecalcified bones and teeth with attached soft tissue. J Oral Pathol 1982;11:318-326.
22. Duarte PM, César-Neto JB, Gonçalves PF, Sallum EA, Nociti FH Jr. Estrogen deficiency affects bone healing around titanium implants. A histometric study in rats. Implant Dent 2003;12:340-345.
23. Zhang X, Morham SG, Langenbach R, et al. Evidence for a direct role of COX-2 in implant wear debris-induced osteolysis. J Bone Miner Res 2001;16:660-670.
24. Zhang X, Schqarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002;109:1405-1415.
25. Komori T, Yagi H, Nomura S, et al. Targeted disruption of cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89:755-764.
26. Harada H, Tagashira S, Fujiwa M, et al. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 1999;274:6972-6978.
27. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 1997;89:747-754.
28. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108:17-29.
29. Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 2003;18: 705-715.
30. Celil AB, Campbell PG. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 2005;280: 31353-31359.
31. Lee MH, Kim YH, Park HD, et al. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 2003;278:34387-34394.
32. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 2003;309:689-694.
33. Kato M, Patel MS, Levasseur R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 2002; 157:303-314.
34. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 2003;278: 45969-45977.
35. Jadlowiec J, Koch H, Zhang X, Campbell PG, Seyedain M, Sfeir C. Phosphophoryn regulates the gene expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the integrin/MAPK signaling pathway. J Biol Chem 2004;279: 53323-53330.
36. Yagi K, Tsuji K, Nifuji A, et al. Bone morphogenetic protein-2 enhances osterix gene expression in chondrocytes. J Cell Biochem 2003;88:1077-1083.
37. Marinho VC, Celletti R, Bracchetti G, Petrone G, Minkin C, Piattelli A. Sandblasted and acid-etched dental implants: A histologic study in rats. Int J Oral Maxillofac Implants 2003;18:75-81.
38. Abrahamsson I, Berglundh T, Linder E, Lang NP, Lindhe J. Early bone formation adjacent to rough and turned endosseous implant surfaces. An experimental study in the dog. Clin Oral Implants Res 2004; 15:381-392.
39. Lazzara RJ, Testori T, Trisi P, Porter SS, Weinstein RL. A human histological analysis of osseotite and machined surfaces using implants with 2 opposing surfaces. Int J Periodontics Restorative Dent 1999;19: 117-129.
40. Weng D, Hoffmeyer M, Hürzeler MB, Richter E-J. The Osseotite vs. machined surface in poor bone quality. A study in dogs. Clin Oral Implants Res 2003;14:703-708.